Decapeptyl 11.25MG

Therapeutic indications
Treatment of patients with locally advanced, non-metastatic prostate cancer, as an alternative to surgical castration.
Treatment of metastatic prostate cancer.
As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
As neoadjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer.
As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression.
Treatment of endometriosis.
Treatment of precocious puberty (onset before 8 years in girls and 10 years in boys).

Link: Decapeptyl

Categories: ,

Description

Decapeptyl SR 11.25 mg, powder for suspension for injection.

Triptorelin (I.N.N.) 15 mg, as triptorelin acetate.
The vial contains an overage to ensure that a dose of 11.25 mg is administered to the patient.

Reviews

There are no reviews yet.

Be the first to review “Decapeptyl 11.25MG”

Your email address will not be published. Required fields are marked *